Investigation the Role of Autophagy in Non-Small Cell Lung Cancer

Minoo Pargol1,2, Shima Zare Karizi1,2, Masoumeh Akbari1,2

  • 1Department of Genetics and Biotechnology, School of Biological Science, Varamin Pishva Branch, Islamic Azad University, Varamin, Iran.

Abstract

Insights

MicroRNAs miR-30d and miR-204-5p are downregulated in non-small cell lung cancer (NSCLC), acting as tumor suppressors. Their target genes are upregulated, suggesting a role in NSCLC progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Autophagy plays a role in various cancers, including lung cancer.
  • MicroRNAs regulate autophagy-related genes, influencing cancer cell behavior.
  • Epigenetic modifications like DNA methylation are implicated in cancer-related autophagy.

Purpose of the Study:

  • To investigate the expression of miR-30d, miR-204-5p, and miR-20a in non-small cell lung cancer (NSCLC).
  • To analyze the expression of their target genes (beclin1, LC3, bcl2, ULK1) in NSCLC.
  • To assess the DNA methylation status of these target genes in NSCLC.

Main Methods:

  • Real-time quantitative PCR (qPCR) was used to measure the expression levels of specific microRNAs and their target genes in 30 NSCLC patient samples and adjacent normal tissues.
  • Methylation-Specific High-Resolution Melting (MS-HRM) analysis was employed to evaluate the DNA methylation of the promoter regions of beclin1, LC3, bcl2, and ULK1 genes.

Main Results:

  • miR-30d and miR-204-5p were significantly downregulated in NSCLC tissues compared to normal adjacent tissues (p=0.01 and P=0.048, respectively).
  • No significant change in miR-20a expression was observed between tumor and normal tissues.
  • Target genes (beclin1, LC3, bcl2, ULK1) showed significantly increased expression in NSCLC tissues.
  • No significant alterations were found in the methylation patterns of the target gene promoters.

Conclusions:

  • miR-30d and miR-204-5p function as tumor suppressor genes in NSCLC.
  • Upregulated target genes may act as oncogenes in NSCLC.
  • These microRNAs and their targets are potentially significant in NSCLC progression, warranting further investigation for therapeutic strategies.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.2K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.4K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.3K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.2K